Nordic Healthcare Group (NHG) ads

Is healthcare software at risk from AI? 🔍 Across software markets, AI is changing the rules fast: ➡️ It lowers the cost of building software. ➡️ It challenges traditional per-seat pricing models. ➡️ It creates room for AI-native competitors to move faster than ever before. That raises a natural question for investors in healthcare IT: does the same disruption thesis apply here? Our view: the threat is real, but contained. AI can accelerate development, but the most durable barriers in healthcare software are not just about writing code. They sit in regulatory conformity, clinical validation, EMR integration, workflow embeddedness, procurement cycles, and trusted deployment data. Here's the thing: AI may make it easier to build software, but it does not make it easy to build clinically adopted, regulated, integrated healthcare software. For investors, that matters. Healthcare IT looks more resilient to AI disruption than the broader SaaS narrative might suggest — but only for providers that treat AI as a strategic necessity, not an optional feature. 👉 We at Nordic Healthcare Group (NHG) have looked at where AI changes the game — and where healthcare software remains structurally protected. Read the full investment perspective: https://lnkd.in/e29CQ5rF//?utm_source=linkedin&utm_medium=paid&utm_id=1003207304&utm_campaign=Strategia%2526M%2526A%257CEngagement&hsa_acc=515219525&hsa_cam=1003207304&hsa_grp=573714914&hsa_ad=1436944593&hsa_net=linkedin&hsa_ver=3

Italy. 44% of doctors are 55 or older. When they retire, who fills the gap? This is not a future problem. Across EU5, ageing physician workforces are meeting accelerating care demand at the exact moment fiscal room to absorb the pressure has closed. The Nordics hit this wall earlier. And they built solutions: telemedicine scaled to millions of reimbursed consultations, automated home-care dispensing running at regional scale, clinical workflow software live across scores of hospitals. None of it transplants wholesale. Kry, Evondos, Medanets — each required deliberate local adaptation when expanding into EU5 markets. But the validated answers exist. And with €40bn+ in EU5 digital health capital now deployed, the window to back the right operators is open. If you are looking for an interesting and validated solution, we can help you find it. We've mapped where the opportunity is sharpest. Read the full investment perspective: #HealthcareInvesting #PrivateEquity #HealthTech #NHG

What can EU5 countries learn from the Nordics? 🔍 Across EU5, three pressures are converging at once: A rapidly ageing population. ➡️ 12+ million more people aged 80+ in EU5 by 2045. A physician workforce already deep into retirement age. ➡️ 44% of doctors in Italy are already 55 or older, 35% in France and 32% in Germany. ➡️ Simultaneously fiscal headroom at a generational low. The arithmetic is unforgiving. The answer has to come from productivity, from technology and new care-delivery models that scale without headcount. Here's the thing: the Nordics have already been through this. Demographic pressure hit harder and earlier, forcing health systems to adapt. A cohort of Nordic companies built real solutions — reimbursed, scaled, iterated — in home care, clinical workflow, medication management, and primary care. As the same pressures intensify across EU5, that validated cohort is unusually well positioned to meet the demand. 👉 We at Nordic Healthcare Group (NHG) have mapped where the opportunity is sharpest. Read the full investment perspective: https://lnkd.in/ed7yrg7j #HealthcareInvesting #PrivateEquity #NHGinsights

Considering an investment in health or social care? Nordic Healthcare Group (NHG) has strong capabilities and knowhow to serve investors on the Nordic health and social care markets with a solid track record of advising investors and providers on projects across the Nordics and Europe. Our Strategy & M&A team supports clients across the full strategy lifecycle — from market scans and growth assessments to strategy formulation and implementation support. With a growing international footprint and strong presence in both the Nordics and Europe, NHG’s mission is to help clients navigate complex and regulated healthcare environments while identifying realistic, sustainable paths for long-term growth. We bring clarity through deep sector insight and proven commercial due diligence.

Over 12 million more people aged 80+ in EU5 by 2045. 44% of Italian doctors are already 55 or older. Public fiscal headroom is at a generational low. Nordic healthcare companies came through exactly the same pressure a decade ago. They are reimbursement-eligible, validated, and ready to expand into EU5. NHG has mapped where the opportunity is sharpest. If you are looking for a validated Nordic target, we take you from investment screening to close.

Nordic Healthcare Group (NHG) continues to expand its Strategy & M&A capabilities in the Nordics ↗️ 💪 We’re excited to welcome Edoardo Angelini-Rota to Nordic Healthcare Group as Senior Manager in our Strategy & M&A team in Sweden. His appointment highlights NHG’s focus on delivering execution‑oriented strategic advisory to social and healthcare organisations, investors and operators. Edoardo brings extensive hands-on experience in growth strategy and value creation across the healthcare and social care sector, with strong exposure to the major EU5 markets. Throughout his career, he has partnered with Private Equity investors, portfolio companies, and healthcare operators, delivering 50+ healthcare commercial due diligences as well as supporting market entry, international expansion and operational performance improvement initiatives. Prior to joining NHG, Edoardo worked at L.E.K Consulting, Value Partners, and Accenture. Edoardo holds an MSc in Aeronautical Engineering from the University of Roma La Sapienza. “I’m very excited to join Nordic Healthcare Group and to work closely with clients on strategic and M&A‑related topics across the Nordics. NHG’s strong platform and deep sector focus make this a unique opportunity,” says Edoardo Angelini-Rota. NHG’s Strategy & M&A team supports clients across the full strategy lifecycle — from market scans and growth assessments to strategy formulation and implementation support. With a growing international footprint and strong presence in both the Nordics and Europe, NHG’s mission is to help clients navigate complex and regulated healthcare environments while identifying realistic, sustainable paths for long-term growth.